| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Analysis of clinical decision-making in multi-disciplinary cancer teams
|
Blazeby, J.M.
|
|
|
17 |
3 |
p. 457-460
|
article
|
| 2 |
An economic evaluation of Herceptin® in adjuvant setting: the Breast Cancer International Research Group 006 trial
|
Neyt, M.
|
|
|
17 |
3 |
p. 381-390
|
article
|
| 3 |
A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol 2005; 16: 1639–1645
|
Oettle, H.
|
|
|
17 |
3 |
p. 535
|
article
|
| 4 |
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patients
|
Viens, P.
|
|
|
17 |
3 |
p. 429-436
|
article
|
| 5 |
Bevacizumab plus high-dose ifosfamide, etoposide and carboplatin (HD-ICE) as third-line salvage chemotherapy induced an unexpected dramatic response in highly platinum refractory germ-cell cancer
|
Voigt, W.
|
|
|
17 |
3 |
p. 531-533
|
article
|
| 6 |
‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa
|
Grünberger, B.
|
|
|
17 |
3 |
p. 484-487
|
article
|
| 7 |
Breaking bad news in oncology: like a walk in the twilight?
|
Aitini, E.
|
|
|
17 |
3 |
p. 359-360
|
article
|
| 8 |
Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factors? A retrospective analysis
|
Lalami, Y.
|
|
|
17 |
3 |
p. 507-514
|
article
|
| 9 |
Catheter-associated thrombosis: thromboprophylaxis for cancer patients who carry factor V Leiden?
|
Ferretti, G.
|
|
|
17 |
3 |
p. 528-529
|
article
|
| 10 |
Cetuximab and irinotecan/5-fluorouracil/folinic acid is a safe combination for the first-line treatment of patients with epidermal growth factor receptor expressing metastatic colorectal carcinoma
|
Folprecht, G.
|
|
|
17 |
3 |
p. 450-456
|
article
|
| 11 |
Characterization of familial Waldenström's macroglobulinemia
|
Treon, S.P.
|
|
|
17 |
3 |
p. 488-494
|
article
|
| 12 |
Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): A meta-analysis of individual data from 1764 patients
|
Aupérin, A.
|
|
|
17 |
3 |
p. 473-483
|
article
|
| 13 |
Folate intake and squamous-cell carcinoma of the oesophagus in Italian and Swiss men
|
Galeone, C.
|
|
|
17 |
3 |
p. 521-525
|
article
|
| 14 |
Follow-up strategy of germ cell tumour patients
|
De Giorgi, U.
|
|
|
17 |
3 |
p. 529-530
|
article
|
| 15 |
Impact of providing booklets about chemotherapy to newly presenting patients with cancer: a randomized controlled trial
|
Iconomou, G.
|
|
|
17 |
3 |
p. 515-520
|
article
|
| 16 |
in this issue
|
|
|
|
17 |
3 |
p. 355
|
article
|
| 17 |
Is high-dose chemotherapy based on carboplatin, a late dose-intensification of a cisplatin-based salvage chemotherapy in germ cell tumour patients?
|
De Giorgi, U.
|
|
|
17 |
3 |
p. 530-531
|
article
|
| 18 |
Lack of response of cetuximab plus oxaliplatin in advanced colorectal cancer patients resistant to both oxaliplatin and cetuximab plus irinotecan
|
Vincenzi, B.
|
|
|
17 |
3 |
p. 527-528
|
article
|
| 19 |
Long-term clinical outcome of somatostatin analogues for treatment of progressive, metastatic, well-differentiated entero-pancreatic endocrine carcinoma
|
Panzuto, F.
|
|
|
17 |
3 |
p. 461-466
|
article
|
| 20 |
Long-term follow-up of a randomised trial designed to determine the need for irradiation following conservative surgery for the treatment of invasive breast cancer
|
Ford, H.T.
|
|
|
17 |
3 |
p. 401-408
|
article
|
| 21 |
Neuropsychological function in high-risk breast cancer survivors after stem-cell supported high-dose therapy versus standard-dose chemotherapy: evaluation of long-term treatment effects
|
Scherwath, A.
|
|
|
17 |
3 |
p. 415-423
|
article
|
| 22 |
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancer
|
Chong, G.
|
|
|
17 |
3 |
p. 437-442
|
article
|
| 23 |
Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
|
Martinelli, G.
|
|
|
17 |
3 |
p. 495-502
|
article
|
| 24 |
Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial
|
Coudert, B.P.
|
|
|
17 |
3 |
p. 409-414
|
article
|
| 25 |
Pulmonary toxicity from novel antineoplastic agents
|
Dimopoulou, I.
|
|
|
17 |
3 |
p. 372-379
|
article
|
| 26 |
Randomised Phase III study of biweekly 24-h infusion of high-dose 5FU with folinic acid and oxaliplatin versus monthly plus 5-FU/folinic acid in first-line treatment of advanced colorectal cancer
|
Hospers, G.A.P.
|
|
|
17 |
3 |
p. 443-449
|
article
|
| 27 |
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial
|
Camps, C.
|
|
|
17 |
3 |
p. 467-472
|
article
|
| 28 |
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patients
|
Mercatali, L.
|
|
|
17 |
3 |
p. 424-428
|
article
|
| 29 |
Survival and prognostic factors in BRCA1-associated breast cancer
|
Brekelmans, C.T.M.
|
|
|
17 |
3 |
p. 391-400
|
article
|
| 30 |
Table of Contents
|
|
|
|
17 |
3 |
p. iv-v
|
article
|
| 31 |
The cost of life: should it matter to doctors?
|
Gianni, Luca
|
|
|
17 |
3 |
p. 357-358
|
article
|
| 32 |
The integration of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: how successful have we been?
|
Glynne-Jones, R.
|
|
|
17 |
3 |
p. 361-371
|
article
|
| 33 |
The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma
|
Stebbing, J.
|
|
|
17 |
3 |
p. 503-506
|
article
|
| 34 |
Unilateral nail changes secondary to adriamycin: the protective effect of brachial plexopathy
|
Bird, B.R.
|
|
|
17 |
3 |
p. 527
|
article
|
| 35 |
Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas
|
Tirelli, U.
|
|
|
17 |
3 |
p. 533
|
article
|
Journal description